Psychiatr. praxi. 2014;15(1):9-14

Chronic insomnia

MUDr.Lucie Závěšická, Ph.D.
Psychiatrická ambulance Clinterap, s. r. o.

Sleep disorders comprise a very heterogeneous group of diseases. In psychiatric practice, we most commonly encounter primary and secondary

insomnia, wherein insomnia is a symptom of another disease. Some tricyclic antidepressants, trazodone, mirtazapine, and melatonin

can be used in treating chronic insomnia. Drugs generally are of additional importance in treating primary insomnia. The most effective

approach is to affect the behavior that is linked to sleep by means of psychotherapy. Currently, cognitive behavioral therapy is considered

to be the most sophisticated and effective method.

Keywords: sleep, insomnia, antidepressants, cognitive behavioral therapy

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Závěšická L. Chronic insomnia. Psychiatr. praxi. 2014;15(1):9-14.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kryger MH, Roth T, Dement WC. Principles and practice of sleep medicine.4th ed. Philadelphia: Elsevier, 2005.
    2. Hajak G, Bandelow B, Zulley J, Pittrow D. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia-assessment of a novel intervention strategy in a primary care setting. Ann Int Clin Psychiatry 2002; 14(1): 1-7. Go to original source...
    3. Taylor DJ, Bramoweth AD, Grieser EA, Tatum JI Roane BM. Epidemiology of insomnia in college students: relationahip with mental health, quality of life, and substance use difficulties. Behav Ther. 2013; 44(3): 339-348. Go to original source... Go to PubMed...
    4. Roth T, Krystal AD, Lieberman JA 3rd. Long-term issues in the treatment of sleep disorders. CNS Spectr. 2007; 12(7 Suppl 10): 1-14. Go to original source... Go to PubMed...
    5. Coleman RM, Roffwarg HP, Kennedy SJ, Guilleminault C, Cinque J, Cohn MA, Karacan I, Kupfer DJ, Lemmi H, Miles LE, Orr WC, Phillips ER, Roth T, Sassin JF, Schmidt HS, Weitzman ED, Dement WC. Sleep-wake disorders based on a polysomnographic diagnosis. A national cooperative study. JAMA. 1982; 247(7): 997-1003. Go to original source... Go to PubMed...
    6. Buysse DJ, Reynolds CF 3rd, Kupfer DJ, Thorpy MJ, Bixler E, Manfredi R, Kales A, Vgontzas A, Stepanski E, Roth T, et al. Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep. 1994; 17(7): 630-637. Go to original source... Go to PubMed...
    7. Lustberg L, Reynolds CF. Depression and insomnia: questions of cause and effect. Sleep Med Rev. 2000; 4(3): 253-262. Go to original source... Go to PubMed...
    8. Léger D, Stal V, Guilleminault C, Raffray T, Dib M, Paillard M. [Diurnal consequence of insomnia: impact on quality of life]. Rev Neurol (Paris). 2001; 157(10): 1270-1278. Go to PubMed...
    9. Avidan AY. Sleep disorders in the older patient. Prim Care. 2005; 32(2): 563-586. Go to original source... Go to PubMed...
    10. Léger D, Stal V, Guilleminault C, Raffray T, Dib M, Paillard M. [Diurnal consequence of insomnia: impact on quality of life]. Rev Neurol (Paris). 2001; 157(10): 1270-1278. Go to PubMed...
    11. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001; 285(14): 1856-1864. Go to original source... Go to PubMed...
    12. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep. 2006; 29: 1398-1414. Go to original source... Go to PubMed...
    13. Espie CA, Kyle SD, Williams Ch, Ong JC, Douglas NJ, Hames P, Brown JSL. A randomized placebo controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via automated media-rich web application. Sleep 2012; 35(6): 769-781. Go to original source... Go to PubMed...
    14. Spielman AJ, Saskin P, Thorpy MJ (1987). Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987; 10: 45-56. Go to PubMed...
    15. Bootzin RR, Nicassio PM. Behavioral treatments for insomnia. In: Hersen M, Eissler R, Miller P, editors. Progress of Behavior Modification. New York: Academic Press, 1978: p 1-45. Go to original source...
    16. Morin CM. Insomnia. Psychological assessment and managment. New York: Guiford Press, 1993: 238.
    17. Praško J, Ticháčková A, Mainerová B, Kamarádová D. Neorganické poruchy spánku. In: Klinická psychiatrie. Praško J, Látová K, Ticháčková A, Stárková L. Tigis, 2011: 418-445.
    18. Závěšická L, Espa-Červená K. Poruchy spánku. In: Konsiliární psychiatrie. Herman E, Praško J, Seifertová D, eds. Praha: Medical Tribune a Galén, 2007: 151-163.
    19. Poyares D, Guilleminault C, Ohayon MM, Tufik S. Chronic benzodiazepine usage and withdrawal in insomnia patients. J Psychiatr Res. 2004; 38(3): 327-334. Go to original source... Go to PubMed...
    20. Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age end endogenous melatonin as predictor of efficacy and safety. BMC Med 2010; 8: 51. Go to original source... Go to PubMed...
    21. Nowell PD, Reynolds CF 3rd, Buysse DJ, Dew MA, Kupfer DJ. Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry 1999; 60(2): 89-95. Go to original source... Go to PubMed...
    22. Le Bon O, Murphy JR, Staner L, Hoffmann G, Kormoss N, Kentos M, Dupont P, Lion K, Pelc I, Verbanck P. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol. 2003; 23(4): 377-383. Go to original source... Go to PubMed...
    23. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, Semler B, Decker K, Parapatics S, Tschida U, Winkler A, Saletu B. Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with Trazodone. Neuropsychobiology 2001; 44(3): 139-149. Go to original source... Go to PubMed...
    24. Saletu B, Saletu-Zyhlarz GM. Sleep laboratory studies with trazodone in insomnia related to derepssion and dysthymia. Čes a slov Psychiat. 2002; 7: 368-376.
    25. Shen J, Chung SA, Kayumov L, Moller H, Hossain N, Wang X, Deb P, Sun F, Huang X, Novak M, Appleton D, Shapiro CM. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine. Can J Psychiatry 2006; 51(1): 27-34. Go to original source... Go to PubMed...
    26. Palomäki H, Berg A, Meririnne E, Kaste M, Lönnqvist R, Lehtihalmes M, Lönnqvist J. Complaints of poststroke insomnia and its treatment with mianserin. Cerebrovasc Dis. 2003; 15(1-2): 56-62. Go to original source... Go to PubMed...
    27. Schwartz T, Nihalani N, Virk S, Jindal S, Costello A, Muldoon R, Azhar N, Hussein J, Tirmazi S. "A comparison of the effectiveness of two hypnotic agents for the treatment of insomnia". Int J Psychiatr Nurs Res. 2004; 10(1): 1146-1150. Go to PubMed...
    28. Roth AJ, McCall WV, Liquori A. Cognitive, psychomotor and polysomnographic effects of trazodon in primary insomniacs. J Sleep Res. 2011; 20(4): 552-558. Go to original source... Go to PubMed...
    29. Švestka J. Nová psychofarmaka: Mirtazapin, noradrenergní a specificky serotonergní antidepresivum. Psychiatrie 1999. Dostupné na http://www.tigis.cz/PSYCHIAT/PSYCH499/07sves.htm.
    30. Winocur A, Sateia MJ, Hayes JB, Bayels-Dazet W, MacDonald MM, Gary KA. Acute effects of mirtazapine on slep kontinuity and sleep archutecture in depressed patiens: a pilot study. Biol Psychiatry 2000; 48(1): 75-78. Go to original source... Go to PubMed...
    31. Wade AG, Ford I, Crawford G, et al. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and nextday alertnessoutcomes. Curr Med Res Opin. 2007; 23(10): 2597-2605. Go to original source... Go to PubMed...
    32. Lemoine P, Nir T, LaudonM, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007; 16(4): 372-380. Go to original source... Go to PubMed...
    33. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorder. PLoS One. 2013; 8(5): e63773. Go to original source... Go to PubMed...
    34. Keshavan MS, Prasad KM, Montrose DM, Miewald JM, Kupfer DJ. Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients. J Clin Psychopharmacol. 2007; 27(6): 703-705. Go to original source... Go to PubMed...
    35. Carney AC. Efficacy of quetiapine off-label uses: Data synthesis. J Psychosoc Nurs Ment Health Serv. 2013; 18: 1-6. Go to original source... Go to PubMed...
    36. Hajak G, Cluydts R, Allain H, Estivill E, Parrino L, Terzano MG, Walsh JK. The challenge of chronic insomnia: is non-nightly hypnotic treatment a feasible alternative? Eur Psychiatry. 2003; 18(5): 201-208. Go to original source... Go to PubMed...
    37. Brower KJ, Kim HM, Strobbe S, Karam-Hage MA, Consens F, Zucker RA. A randomised double-blind pilot trialof gabapentin vs.placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res. 2008; 32(8): 1429-1438. Go to original source... Go to PubMed...
    38. Di Iorio G, Matarazzo I, Di Tizio L, Martinotti G. treatment-resistant insomnia treated with pregabalin. Eur Rev Med Pharmacol Sci. 2013; 17(11): 1552-1554. Go to PubMed...
    39. Edinger JD, Ulmer CS, Means MK. Sensitivity and specifity of polysomnographic criteria for defining insomnia. J Clin Sleep Med. 2013; 9(5): 481-491. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.